RTVP-1 Gene Therapy (Baylor College of Medicine)

N/A

Report date: 2024/09/10 15:25:10

Base Information

Drug NameRTVP-1 Gene Therapy (Baylor College of Medicine)
Drug Alias NameAdmRTVP-1RTVP-1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionGlioma pathogenesis-related protein 1 stimulants
TargetsGlioma pathogenesis-related protein 1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaylor College Of Medicine
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG